Godavari Biorefineries Ltd

Godavari Biorefineries Ltd has announced the re-appointment of Mr. Nitin Mehta as an Independent Director for a five-year term starting July 1, 2026, and Dr. Sangeeta Srivastava as a Whole Time Director (Executive Director) for a three-year term commencing August 1, 2026. These re-appointments were approved by shareholders via postal ballot. Both directors have confirmed they are not debarred from holding directorships by any regulatory authority and have no inter-se relationships with other directors.

Godavari Biorefineries Limited has announced the commencement of its new corn/grain-based distillery at its Sameerwadi Unit, effective June 29, 2026. This expansion adds a proposed capacity of 200 KLPD, complementing its existing 600 KLPD sugarcane-based capacity. The project involved an investment of approximately ₹130 Cr, financed through internal accruals and debt. The dual-feedstock capability is expected to enhance ethanol production resilience, particularly during climate disruptions, and position the company to meet the increasing demand driven by India's ethanol blending program.

Godavari Biorefineries Ltd has announced the closure of its trading window for all Directors, Key Managerial Persons, Designated Persons, and their immediate relatives. This closure is in compliance with SEBI's Insider Trading Regulations, 2015. The window will be shut from July 1st, 2026, until 48 hours after the declaration of the financial results for the quarter ending June 30th, 2026. The exact date for the board meeting to consider these results will be communicated later.

Godavari Biorefineries Ltd has announced that the Japanese Patent Office has granted them a patent for "5-HYDROXY-1,4-NAPHTHALENEDIONE FOR USE IN THE TREATMENT OF CANCER." This novel compound has demonstrated significant efficacy against various cancer types, including breast and prostate cancer, by exhibiting strong inhibitory effects on cancer and cancer stem cells. The patent grant is a significant development for the company's biopharmaceutical research and development efforts.

Godavari Biorefineries Limited announced that the Indian Patent Office has granted patent application no. 202021023138, titled "A PROCESS FOR PRODUCTION OF BRANCHED ALCOHOL". This invention describes a safe, economic, and cost-effective process for producing branched alcohols. The company highlighted that this patent grant strengthens its intellectual property protection in the bio-based specialty chemicals segment. The patent is valid for a term of 20 years from June 2, 2020.

Godavari Biorefineries Ltd's Board Meeting on May 22, 2026, approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The board also approved the re-appointment of Dr. Sangeeta Srivastava as Executive Director, Mr. Nitin Mehta as Non-Executive Independent Director, Mr. Samir S. Somaiya as Managing Director and Mr. Suhas Godage as Whole Time Director. Additionally, Mr. Dinesh Sharma was appointed as Whole Time Director. M/s R. Nanabhoy & Co was appointed as Cost Auditor for FY 2026-27.

Godavari Biorefineries Ltd has scheduled a Board of Directors meeting on May 22, 2026, to consider and approve the audited financial results for the quarter and year ended March 31, 2026. In compliance with SEBI regulations, the trading window remains closed from April 1, 2026, until 48 hours after the declaration of the financial results.

Godavari Biorefineries Ltd has announced that it has achieved the highest crushing of 2.5 million tonnes till date during the crushing session 25-26 at the Sameerwadi unit. This is the highest ever crushing in the history of the Company in one crushing session. The crushing session will end on 7th April, 2026.

Godavari Biorefineries Ltd has announced the closure of its trading window for dealing in the securities of the company. The closure is in accordance with the company's 'Insider Trading Prohibition Code' under the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015. The closure will be effective from 1st April, 2026 till 48 hours after declaration of Financial Results for the quarter and year ending 31st March 2026. The date of consideration of the Financial Results for the quarter and year ending 31st March 2026 will be intimated in due course.

Godavari Biorefineries Ltd. has announced that its Japanese patent application titled 'Use of Compounds for Treating Viral Infections' (No. 2022-568620) has been granted by the Japan Patent Office. The patent covers the use of compounds for inhibiting V-ATPase activity in a cell and methods for treating viral infections using these compounds. This grant strengthens the company's intellectual property protection in Japan and adds value to its portfolio in the antiviral therapeutics sector.